newsfilter
← Latest News
GlobeNewswire·

VLB Therapeutics to Report Year-End 2021 Financial Results on March 23

TEL AVIV, Israel and NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a late-clinical stage biotechnology company focused on developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune or